Oct 21, 2019
Scientists ‘may have crossed ethical line’ in growing human brains
Posted by Genevieve Klien in category: neuroscience
Debate needed over research with ‘potential for something to suffer’, neuroscientists say.
Page 7348
Oct 21, 2019
A school in China is monitoring students with facial-recognition technology that scans the classroom every 30 seconds
Posted by Omuterema Akhahenda in category: education
The technology scans classrooms at Hangzhou No. 11 High School every 30 seconds and records students’ facial expressions, categorizing them into happy, angry, fearful, confused, or upset. The system also records student actions such as writing, reading, raising a hand, and sleeping at a desk.
The system is analyzing students’ emotions and actions in the classroom to tell whether they are happy, angry, or confused and to monitor whether they are working or sleeping at their desk. The facial-recognition technology has also replaced ID cards and wallets at the library and canteen.
Oct 21, 2019
Why should you always assume you’re wrong? Science
Posted by Mark Larkento in categories: evolution, neuroscience, science
Assumptions: The Case Against Reality
When it comes to scientific theory, (or your personal life) be sure to question everything.
Continue reading “Why should you always assume you’re wrong? Science” »
Summary: Although musical perception is universal, musical training alters the perception of music. Source: UPF BarcelonaFrom a general perspective, harmony in music is the balance of the prop.
Oct 21, 2019
UPS Strikes Agreements to Use Drones to Deliver Medical Supplies
Posted by Genevieve Klien in categories: biotech/medical, drones, habitats, health
United Parcel Service Inc. is striking a series of drone-delivery agreements with health-care groups as it develops new technology pitched to the growing medical market.
The plans include expanding the use of drones to deliver cargo such as medical samples and supplies on hospital campuses in Utah and elsewhere, and an agreement with CVS Health Corp. to evaluate the use of drones for home delivery of prescriptions and other products, UPS said Monday.
The agreements are the first UPS has announced since the package delivery giant won U.S. regulatory approval to operate commercial drone flights through the company’s Flight Forward subsidiary. The nod from the Federal Aviation Administration paves the way for UPS to scale up operations as it competes with FedEx Corp., Amazon.com Inc. and others vying to develop drone delivery services in the U.S.
Oct 21, 2019
Scientists Want to Try Using Shrooms to Revive People in Vegetative States
Posted by Paul Battista in category: neuroscience
Here is another amazing piece!
Does psilocybin have the potential to increase consciousness in people who are unresponsive?
Oct 21, 2019
Achieving Viable Mind Uploading via Our Understanding of Brain Lateralization
Posted by B.J. Murphy in categories: futurism, neuroscience
Could a rare neurological disorder and a radical surgical operation pave the way towards a future of viable mind uploading?
Oct 21, 2019
What happens if your mind lives for ever on the internet?
Posted by Paul Battista in category: neuroscience
It may be some way off, but mind uploading, the digital duplication of your mental essence, could expand human experience into a virtual afterlife.
Oct 21, 2019
What if we could create new, life-saving organs from scratch?
Posted by Paul Battista in category: biotech/medical
Oct 21, 2019
James Peyer at Ending Age-Related Diseases 2019
Posted by Steve Hill in categories: finance, life extension
We’re continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.
James Peyer of Kronos BioVentures gave a talk about the investment aspects of rejuvenation biotechnology, first explaining the effects of the population pyramid, showing the audience why cures for age-related diseases are such a necessity, and comparing population projections. He explained the startup ecosystem in biotechnology, drug approval, and IPO prices for nascent biotechnology companies. Finally, he explained the financial issues facing startup biotechnology companies and his company’s role in helping these companies achieve their goals.
Continue reading “James Peyer at Ending Age-Related Diseases 2019” »
